Scientific article
English

Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence

Published in

Journal of hepatology, vol. 63, no. 6, p. 1449-1458

Publication date

2015

Abstract

Recurrence of primary biliary cirrhosis (PBC) after liver transplantation (LT) is not rare and can occasionally lead to severe graft dysfunction and retransplantation. Ursodeoxycholic acid (UDCA) is a safe and effective treatment for PBC. However, whether preventive administration of UDCA after LT could lower the incidence of PBC recurrence is unknown.

UNIGE research groups

Citation (ISO format)

BOSCH, Alexie et al. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence. In: Journal of hepatology, 2015, vol. 63, n° 6, p. 1449–1458. doi: 10.1016/j.jhep.2015.07.038

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

0168-8278
605views
0downloads

Technical informations

Creation

15/01/2016 08:24:00

First validation

15/01/2016 08:24:00

Update

15/03/2023 00:09:07

Status update

15/03/2023 00:09:06

Last indexation

31/10/2024 02:47:15
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated